Dr. Reddy's Laboratories Ltd. - Research Center
500124 DRREDDY Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 19,483.80 | 16,962.50 | 14,405.20 | 13,349.10 | 11,850.40 |
| Expenses | |||||
| Material consumed | 5,942.10 | 5,773.30 | 5,578.00 | 4,650.50 | 4,058.00 |
| Manufacturing expenses | 454.40 | 398.10 | 326.80 | 291.30 | 290.50 |
| Personnel expenses | 3,085.70 | 2,832.60 | 2,434.60 | 2,270.10 | 2,030.20 |
| Selling expenses | 140.60 | 69.80 | 82.60 | 37.00 | 12.20 |
| Adminstrative expenses | 3,934.60 | 3,673.90 | 3,389.10 | 2,963.40 | 2,589.90 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 13,557.40 | 12,747.70 | 11,811.10 | 10,212.30 | 8,980.80 |
| Operating profit | 5,926.40 | 4,214.80 | 2,594.10 | 3,136.80 | 2,869.60 |
| Other recurring income | 862.30 | 591.30 | 482.00 | 801.10 | 743.20 |
| Adjusted PBDIT | 6,788.70 | 4,806.10 | 3,076.10 | 3,937.90 | 3,612.80 |
| Financial expenses | 21.80 | 16.90 | 38.00 | 46.70 | 47.80 |
| Depreciation | 975.60 | 923.20 | 814.30 | 835.00 | 789.20 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 5,791.30 | 3,866.00 | 2,223.80 | 3,056.20 | 2,775.80 |
| Tax charges | 1,449.30 | 1,253.20 | 600.60 | 869.80 | -161.90 |
| Adjusted PAT | 4,342.00 | 2,612.80 | 1,623.20 | 2,186.40 | 2,937.70 |
| Non recurring items | 0.10 | - | - | 0.30 | 0.50 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 4,342.10 | 2,612.80 | 1,623.20 | 2,186.70 | 2,938.20 |
| Earnigs before appropriation | 21,846.90 | 18,015.80 | 15,760.50 | 14,684.60 | 12,889.30 |
| Equity dividend | 664.80 | 497.90 | 414.60 | 414.70 | 391.40 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 21,182.10 | 17,517.90 | 15,345.90 | 14,269.90 | 12,497.90 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis